Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAU-284 (bepotastine besilate) in pediatric atopic dermatitis
NCT01840605Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Mar 2013
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bepotastine in atopic dermatitis (AD), sponsored by Mitsubishi Tanabe Pharma. Started Mar 2013; status: completed.
02
Drugs
bepotastine
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01840605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01840605.